GE HEALTHCARE DHARMACON INC has a total of 12 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, organic fine chemistry and pharmaceuticals are WINGS THERAPEUTICS INC, REPAIRON GMBH and CELLULAR DYNAMICS INTERNAT INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Organic fine chemistry | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Combinatorial chemistry | |
#3 | Therapeutic chemical compounds | |
#4 | Measuring microorganism processes | |
#5 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Leake Devin | 6 |
#2 | Vermeulen Annaleen | 5 |
#3 | Khvorova Anastasia | 4 |
#4 | Licon Abel | 4 |
#5 | Culver Brady | 4 |
#6 | Stahl Joshua A | 4 |
#7 | He Kaizhang | 3 |
#8 | Karpilow Jon | 3 |
#9 | Delaney Michael Oren | 3 |
#10 | Anderson Emily Marie | 3 |
Publication | Filing date | Title |
---|---|---|
CN107709555A | The unidirectional of synthesis for the gene editing of Cas9 mediations leads RNA | |
AU2014205648A1 | Templates, libraries, kits and methods for generating molecules | |
EP1986697A2 | Compositions and methods for inhibiting gene silencing by rna interference |